SABCS 2021 - ER-positive breast cancers have ...

oncoXchange |

December 2021

ESMO 2021 - MONALEESA-2: Ribociclib extends O ...

oncoXchange |

October 2021

ESMO 2021 - Immunotherapy, CDK4/6 inhibition ...

oncoXchange |

October 2021

ESMO 2021 - Immunotherapy but not PARP inhibi ...

oncoXchange |

September 2021

ASCO 2021 - Studies confirm utility of MammaP ...

oncoXchange |

June 2021

ASCO 2021 - CDK4/6 inhibition maintains impro ...

oncoXchange |

June 2021

SABCS 2020 - Immunotherapy knowledge in breas ...

oncoXchange |

December 2020

SABCS 2020 - Personalized HER2 strategies ext ...

oncoXchange |

December 2020

SABCS 2020 - COVID-19 aftermath its global di ...

oncoXchange |

December 2020

SABCS 2020 - Identifying optimal adjuvant Rx ...

oncoXchange |

December 2020